13D Filing: Aisling Capital III LP and Loxo Oncology Inc. (LOXO)

Page 2 of 13

Page 2 of 13 – SEC Filing

CUSIP No. 548862101
SCHEDULE 13D
Page 2 of 13

1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aisling Capital III, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
3,688,920
8
SHARED VOTING POWER
0
9
SOLE DISPOSITIVE POWER
3,688,920
10
SHARED DISPOSITIVE POWER
0
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,688,920
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.3% (See Item 5)
14
TYPE OF REPORTING PERSON
PN

Follow Loxo Oncology Inc. (NASDAQ:LOXO)

Page 2 of 13